Accentia Biopharmaceuticals, Inc. · Tampa, FL United States
Company Description
Phone: 813-864-2554
Fax: 813-258-6912
More Companies in: Tampa, Florida
More Companies in These Related Industries: Pharmaceutical Preparation Mfg
View Accentia Biopharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Accentia Biopharmaceuticals emphasizes runny noses. The company acquires and develops treatments for respiratory conditions, as well as other ailments. Its development-stage drugs include sinus inflammation treatment SinuNase, multiple sclerosis drug Revimmune, and BiovaxID, a possible vaccine for non-Hodgkin's lymphoma being developed by majority-owned subsidiary Biovest International . Accentia also develops cell production instruments, including the AutovaxID system, and offers pharmaceutical consulting services. The company and its subsidiaries (including Biovest) filed for Chapter 11 bankruptcy protection in late 2008. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Accentia Biopharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Accentia Biopharmaceuticals, Inc. Financials
| Company Type | Public Headquarters |
| Fiscal Year-End | September |
| Employees | 140 |
Accentia Biopharmaceuticals, Inc. Executives
16 executives listed for Accentia Biopharmaceuticals, Inc.'s Tampa, FL location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Francis O'Donnell | |
| President, General Counsel, and Director | Samuel Duffey | |
| CFO and Director | Alan Pearce |
Competition
Competitive Landscape for Accentia Biopharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Accentia Biopharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!